At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 75 million people a year and support our Mission to alleviate pain, restore health, and extend life.
Our people make it possible. We value diverse perspectives and encourage our 90,000+ employees to be themselves. We hold each other accountable, act with integrity, and make quality our highest priority.
We are privileged to be part of the communities where we live and work. We are committed to giving back and reducing our impact on the environment.
Let's take healthcare Further, Together.
ONYX ONE Randomized Trial and ONYX ONE CLEAR Study : Evolution of Evidence for Abbreviated DAPT in High Bleeding Risk Patients Lecturer: David E. Kandzari |
Management of Patients with HBR Using Resolute Onyx in Real Practice Lecturer: Hyo-Soo Kim |
How Did I Treat My Patients with Telescope Lecturer: Jun Ted Chong |
4Y Outcome of Asian Population in IN.PACT DCB Lecturer: Young-Guk Ko |
Clinical Outcomes Comparison of All Drug Devices to Treat FP Disease Lecturer: Su Hong Kim |
Drug-Coated Balloon in Combination with Nitinol Stent Strategy for Peripheral Artery Disease Lecturer: Sang-Su Lee |
Catheter-based Renal Denervation in the Absence of Antihypertensive Medications : Primary Results from the SPYRAL HTN OFF MED Pivotal Trial Lecturer: David E. Kandzari |
Real-World Outcomes of Renal Denervation Lecturer: Ying-Hsiang Lee |
RDN in Clinical Practice : Asia Renal Denervation Consortium (ARDeC) Lecturer: Tiong-Kiam Ong |
Patient Life Expectancy vs Expected Durability of THV: Knowns and Unknowns Lecturer: Lars Sondergaard |